Back to 
HBK Investments L.P.
HBK Investments L.P.
AR2
Showing 0 of 3 quarters
Position history for HBK Investments L.P.'s holdings in ARRAY BIOPHARMA INC
As of its Q2 2019 13F, HBK Investments held 3,486,602 shares of AR2 (Array Biopharma), worth $161.5M. HBK Investments' 13F filings listed AR2 from Q1 2019 to Q2 2019, 2 quarterly filings. AR2 was 1.4% of HBK Investments' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.